CoChat
Sign Up
Cited by 36

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers

Dakhoul, Lara, Ghabril, Marwan, Gu, Jiezhun, Navarro, Victor, Chalasani, Naga, Serrano, Jose·2018·Clinical Gastroenterology and Hepatology
DOI 10.1016/j.cgh.2017.12.036PMC PMC5911195
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2017.12.036

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. Stine, 2017, Drug hepatotoxicity: environmental factors, Clin Liver Dis, 21, 103, 10.1016/j.cld.2016.08.008 · DOI
  2. Schmidt, 2002, Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity, Hepatology, 35, 876, 10.1053/jhep.2002.32148 · DOI
  3. Danan, 1993, Causality assessment of adverse reactions to drugs: a novel method based on the conclusions of international consensus meetings—application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  4. Benichou, 1993, Causality assessment of adverse reactions to drugs: II—an original model for validation of drug causality assessment methods: case reports with positive rechallenge, J Clin Epidemiol, 46, 1331, 10.1016/0895-4356(93)90102-7 · DOI · Paper page
  5. Malatjalian, 1996, Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up, Can J Gastroenterol, 10, 369
  6. Whiting-O'Keefe, 1991, Methotrexate and histologic hepatic abnormalities: a meta-analysis, Am J Med, 90, 711, 10.1016/S0002-9343(05)80060-9 · DOI
  7. Cross, 1980, Rifampin-isoniazid therapy of alcoholic and nonalcoholic tuberculous patients in a U.S. Public Health Service Cooperative Therapy Trial, Am Rev Respir Dis, 122, 349
  8. Pande, 1996, Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study, Thorax, 51, 132, 10.1136/thx.51.2.132 · DOI
  9. Fountain, 2005, Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic, Chest, 128, 116, 10.1378/chest.128.1.116 · DOI
  10. Dossing, 1996, Liver injury during antituberculosis treatment: an 11-year study, Tuber Lung Dis, 77, 335, 10.1016/S0962-8479(96)90098-2 · DOI
  11. Schaberg, 1996, Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis, Eur Respir J, 9, 2026, 10.1183/09031936.96.09102026 · DOI
  12. Chalasani, 2008, Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States, Gastroenterology, 135, 1924, 10.1053/j.gastro.2008.09.011 · DOI
  13. Fontana, 2009, Drug induced liver injury network (DILIN) prospective study: rationale, design and conduct, Drug Saf, 32, 55, 10.2165/00002018-200932010-00005 · DOI · Paper page
  14. Chalasani, 2015, Drug-induced liver injury in the United States: a report of 899 events prospectively assessed, Gastroenterology, 148, 1340, 10.1053/j.gastro.2015.03.006 · DOI · Paper page
  15. Fontana, 2015, Persistent liver injury is more common in older patients and those with cholestatic drug induced liver injury, Am J Gastroenterol, 110, 1450, 10.1038/ajg.2015.283 · DOI
  16. Davern, 2011, Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury, Gastroenterology, 141, 1665, 10.1053/j.gastro.2011.07.051 · DOI
  17. Chalasani, 2013, Acute liver injury due to Flavocoxid (limbrel), a medical food for osteoarthritis: a case series, Ann Intern Med, 156, 857, 10.7326/0003-4819-156-12-201206190-00006 · DOI
  18. Kleiner, 2013, Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations, Hepatology, 59, 661, 10.1002/hep.26709 · DOI
  19. Molleston, 2011, Characteristics of drug induced liver injury in children: interim results from the DILIN Prospective Study, J Pedia Gastro Hepatol, 53
  20. Ross, 1990, Diagnostic validity of the MAST and the alcohol dependence scale in the assessment of DSM-III alcohol disorders, J Stud Alcohol, 51, 506, 10.15288/jsa.1990.51.506 · DOI
  21. Doyle, 2009, A validation study of the Alcohol Dependence Scale, J Stud Alcohol Drugs, 70, 689, 10.15288/jsad.2009.70.689 · DOI
  22. Dodge, 2011, The use of anabolic androgenic steroids and polypharmacy: a review of literature, Drug Alcohol Depend, 114, 100
  23. Gaude, 2015, Drug induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients, J Family Medicine and Primary Care, 4, 238, 10.4103/2249-4863.154661 · DOI
  24. Lewis, 2014, Causality assessment: which is best—expert opinion or RUCAM, Clin Liver Dis, 4, 4, 10.1002/cld.365 · DOI
  25. Martinez, 2015, Clinical and histopathologic features of azithromycin-induced liver injury, Clin Gastroenterol Hepatol, 13, 369, 10.1016/j.cgh.2014.07.054 · DOI
  26. Heidemann, 2016, Severe acute hepatocellular injury attributed to oxyelite pro: a case series, Dig Dis Sci, 61, 2741, 10.1007/s10620-016-4181-7 · DOI

Cited by

Sorted by citations

Metadata

Authors
Dakhoul, L., Ghabril, M., Gu, J., Navarro, V., Chalasani, N., & Serrano, J.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2018-05
Volume
16
Issue
5
Pages
722-729.e2
ISSN
1542-3565
DOI
10.1016/j.cgh.2017.12.036
PMC
PMC5911195
Cited by
36
References
1
Language
en
Licence
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (2U01-DK065176-06, 2U01-DK065201-06, 2U01-DK065184-06, 2U01-DK065211-06, 5U01DK065193-04, 5U01-DK065238-08, 1U01-DK083023-01, 1U01-DK083027-01, 1U01-DK082992-01, 1U01-DK083020-01)
  • CTSA (UL1 RR025761, UL1TR000083, UL1 RR024134, UL1 RR024986, UL1 RR024982, UL1 RR024150)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review